Arizti-Sanz, Jon http://orcid.org/0000-0002-4092-9952
Freije, Catherine A. http://orcid.org/0000-0002-1939-3102
Stanton, Alexandra C.
Petros, Brittany A. http://orcid.org/0000-0003-2110-7475
Boehm, Chloe K. http://orcid.org/0000-0002-6136-3257
Siddiqui, Sameed
Shaw, Bennett M. http://orcid.org/0000-0002-0180-6802
Adams, Gordon
Kosoko-Thoroddsen, Tinna-Solveig F.
Kemball, Molly E.
Uwanibe, Jessica N.
Ajogbasile, Fehintola V.
Eromon, Philomena E.
Gross, Robin
Wronka, Loni
Caviness, Katie
Hensley, Lisa E.
Bergman, Nicholas H.
MacInnis, Bronwyn L.
Happi, Christian T.
Lemieux, Jacob E.
Sabeti, Pardis C.
Myhrvold, Cameron http://orcid.org/0000-0002-8971-184X
Article History
Received: 14 July 2020
Accepted: 7 September 2020
First Online: 20 November 2020
Competing interests
: C.A.F., P.C.S., and C.M. are inventors on patent PCT/US2018/022764, which covers the SHERLOCK and HUDSON technology for viral RNA detection held by the Broad Institute. J.A.-S., C.A.F., A.C.S., B.A.P., P.C.S., and C.M. are inventors on a pending patent application held by the Broad Institute (U.S. Provisional Patent Application No. 63/074,307). This pending application covers the SHINE technology and all designed sequences used in this work. J.E.L. consults for Sherlock Biosciences, Inc. P.C.S. is a co-founder of, shareholder in, and advisor to Sherlock Biosciences, Inc., as well as a Board member of and shareholder in Danaher Corporation. All other authors declare no competing interests.